Fonte: Fortune
Dr. Danish Nagda, a shareholder in the developer, told Fortune it was "incredibly exciting . .
Ler na Fonte
Notícias Relacionadas
Lista de Notícias
Why Wall Street sees a $39,800 pancreatic cancer pill as proof of a much bigger bet
Wall Street
Fortune
há 9h
